advertisement
Journal of Controlled Release 26
Showing records 1 to 25 | Display all abstracts in Journal of Controlled Release125914 Lipid nanoparticle-mediated intracameral mRNA delivery facilitates gene expression and editing in the anterior chamber of the eye
Vasudevan A
Journal of Controlled Release 2025; 379: 1022-1028
126833 Disclosing long-term tolerance, efficacy and penetration properties of hyaluronic acid-coated latanoprost-loaded liposomes as chronic glaucoma therapy
Brugnera M
Journal of Controlled Release 2025; 379: 730-742
126796 Intranasal delivery of epigallocatechin gallate-laden platelet extracellular vesicles for mitigating retinal glaucoma
Pan WY
Journal of Controlled Release 2025; 381: 113596
125914 Lipid nanoparticle-mediated intracameral mRNA delivery facilitates gene expression and editing in the anterior chamber of the eye
Jozić A
Journal of Controlled Release 2025; 379: 1022-1028
126833 Disclosing long-term tolerance, efficacy and penetration properties of hyaluronic acid-coated latanoprost-loaded liposomes as chronic glaucoma therapy
Vicario-de-la-Torre M
Journal of Controlled Release 2025; 379: 730-742
126796 Intranasal delivery of epigallocatechin gallate-laden platelet extracellular vesicles for mitigating retinal glaucoma
Weng PW
Journal of Controlled Release 2025; 381: 113596
125914 Lipid nanoparticle-mediated intracameral mRNA delivery facilitates gene expression and editing in the anterior chamber of the eye
Curtis AG
Journal of Controlled Release 2025; 379: 1022-1028
126833 Disclosing long-term tolerance, efficacy and penetration properties of hyaluronic acid-coated latanoprost-loaded liposomes as chronic glaucoma therapy
González-Cela-Casamayor MA
Journal of Controlled Release 2025; 379: 730-742
126796 Intranasal delivery of epigallocatechin gallate-laden platelet extracellular vesicles for mitigating retinal glaucoma
Wu SH
Journal of Controlled Release 2025; 381: 113596
125914 Lipid nanoparticle-mediated intracameral mRNA delivery facilitates gene expression and editing in the anterior chamber of the eye
Bodi E
Journal of Controlled Release 2025; 379: 1022-1028
126833 Disclosing long-term tolerance, efficacy and penetration properties of hyaluronic acid-coated latanoprost-loaded liposomes as chronic glaucoma therapy
González-Fernández FM
Journal of Controlled Release 2025; 379: 730-742
126796 Intranasal delivery of epigallocatechin gallate-laden platelet extracellular vesicles for mitigating retinal glaucoma
Hsiao CH
Journal of Controlled Release 2025; 381: 113596
125914 Lipid nanoparticle-mediated intracameral mRNA delivery facilitates gene expression and editing in the anterior chamber of the eye
Ryals RC
Journal of Controlled Release 2025; 379: 1022-1028
126833 Disclosing long-term tolerance, efficacy and penetration properties of hyaluronic acid-coated latanoprost-loaded liposomes as chronic glaucoma therapy
Ferraboschi I
Journal of Controlled Release 2025; 379: 730-742
126796 Intranasal delivery of epigallocatechin gallate-laden platelet extracellular vesicles for mitigating retinal glaucoma
Jheng PR
Journal of Controlled Release 2025; 381: 113596
125914 Lipid nanoparticle-mediated intracameral mRNA delivery facilitates gene expression and editing in the anterior chamber of the eye
Sahay G
Journal of Controlled Release 2025; 379: 1022-1028
126833 Disclosing long-term tolerance, efficacy and penetration properties of hyaluronic acid-coated latanoprost-loaded liposomes as chronic glaucoma therapy
Andrés-Guerrero V
Journal of Controlled Release 2025; 379: 730-742
126796 Intranasal delivery of epigallocatechin gallate-laden platelet extracellular vesicles for mitigating retinal glaucoma
Nguyen HN
Journal of Controlled Release 2025; 381: 113596
126833 Disclosing long-term tolerance, efficacy and penetration properties of hyaluronic acid-coated latanoprost-loaded liposomes as chronic glaucoma therapy
Nicoli S
Journal of Controlled Release 2025; 379: 730-742
126796 Intranasal delivery of epigallocatechin gallate-laden platelet extracellular vesicles for mitigating retinal glaucoma
Tseng CL
Journal of Controlled Release 2025; 381: 113596
126833 Disclosing long-term tolerance, efficacy and penetration properties of hyaluronic acid-coated latanoprost-loaded liposomes as chronic glaucoma therapy
Sissa C
Journal of Controlled Release 2025; 379: 730-742
126796 Intranasal delivery of epigallocatechin gallate-laden platelet extracellular vesicles for mitigating retinal glaucoma
Burnouf T
Journal of Controlled Release 2025; 381: 113596
126833 Disclosing long-term tolerance, efficacy and penetration properties of hyaluronic acid-coated latanoprost-loaded liposomes as chronic glaucoma therapy
Pescina S
Journal of Controlled Release 2025; 379: 730-742
126796 Intranasal delivery of epigallocatechin gallate-laden platelet extracellular vesicles for mitigating retinal glaucoma
Rethi L; Nguyen HT
Journal of Controlled Release 2025; 381: 113596
126833 Disclosing long-term tolerance, efficacy and penetration properties of hyaluronic acid-coated latanoprost-loaded liposomes as chronic glaucoma therapy
Herrero-Vanrell R; Bravo-Osuna I
Journal of Controlled Release 2025; 379: 730-742
